Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.17−0.02 (-0.63%)
Close on Nov 18, 2026Market cap $1.17BP/E 15.8Yield –
Cronos shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cronos's shares outstanding was 375M at Jun 30, 2026. For fiscal 2025 it was 383M, down 0.5% from the year before. The highest annual figure on record is 386M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 383M | -0.5% |
| FY2024 | Dec 31, 2024 | 386M | +1.2% |
| FY2023 | Dec 31, 2023 | 381M | +1.1% |
| FY2022 | Dec 31, 2022 | 377M | +1.8% |
| FY2021 | Dec 31, 2021 | 370M | +5.4% |
| FY2020 | Dec 31, 2020 | 352M | +2.6% |
| FY2019 | Dec 31, 2019 | 343M | +99.0% |
| FY2018 | Dec 31, 2018 | 172M | -2.6% |
| FY2017 | Dec 31, 2017 | 177M | +125.9% |
| FY2016 | Dec 31, 2016 | 78M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 375M | -2.7% |
| Q1 FY2026 | Mar 31, 2026 | 382M | -1.3% |
| Q4 FY2025 | Dec 31, 2025 | 383M | -3.5% |
| Q3 FY2025 | Sep 30, 2025 | 385M | -0.3% |
| Q2 FY2025 | Jun 30, 2025 | 385M | +0.8% |
| Q1 FY2025 | Mar 31, 2025 | 387M | +1.4% |
| Q4 FY2024 | Dec 31, 2024 | 396M | +4.0% |
| Q3 FY2024 | Sep 30, 2024 | 386M | +1.3% |
| Q2 FY2024 | Jun 30, 2024 | 382M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | 381M | +0.2% |
| Q4 FY2023 | Dec 31, 2023 | 381M | +0.7% |
| Q3 FY2023 | Sep 30, 2023 | 381M | +0.8% |
| Q2 FY2023 | Jun 30, 2023 | 381M | +1.3% |
| Q1 FY2023 | Mar 31, 2023 | 381M | +1.5% |
| Q4 FY2022 | Dec 31, 2022 | 379M | +1.2% |
| Q3 FY2022 | Sep 30, 2022 | 378M | +0.7% |
| Q2 FY2022 | Jun 30, 2022 | 376M | +1.2% |
| Q1 FY2022 | Mar 31, 2022 | 375M | +3.3% |
| Q4 FY2021 | Dec 31, 2021 | 374M | +31.8% |
| Q3 FY2021 | Sep 30, 2021 | 376M | +0.5% |
| Q2 FY2021 | Jun 30, 2021 | 372M | +6.5% |
| Q1 FY2021 | Mar 31, 2021 | 363M | -3.0% |
| Q4 FY2020 | Dec 31, 2020 | 284M | -23.3% |
| Q3 FY2020 | Sep 30, 2020 | 374M | +1.2% |
| Q2 FY2020 | Jun 30, 2020 | 349M | -6.8% |
| Q1 FY2020 | Mar 31, 2020 | 374M | +38.1% |
| Q4 FY2019 | Dec 31, 2019 | 370M | – |
| Q3 FY2019 | Sep 30, 2019 | 369M | – |
| Q2 FY2019 | Jun 30, 2019 | 375M | – |
| Q1 FY2019 | Mar 31, 2019 | 271M | – |
See a number that looks wrong?